Table 1 Studies used for the second and third levels of our meta-analysis: genes expressed differently in the transition from normal prostate and localized prostate cancer to metastatic disease (Oncomine datasets)
From: Prioritizing genes associated with prostate cancer development
Primary author's name | PMID | Tissue type (no. of samples) Class 1 Class 2 | Total no. of genes | Level |
|---|---|---|---|---|
Dhanasekaran | 11518967 | Normal prostate (22) Primary prostate cancer (59) | 9,956 | 2 |
Dhanasekaran_2 | 15548588 | Normal adjacent prostate (12) Prostate cancer (25) | 19,650 | 2 |
Holzbeierlein | 14695335 | Normal prostate (4) Prostate cancer (23) | 5,854 | 2 |
Lapointe | 14711987 | Normal prostate (41) Prostate carcinoma (62) | 19,116 | 2 |
Luo | 11406537 | Benign hyperplasia (9) Prostate carcinoma (16) | 6,500 | 2 |
Nanni | 16513839 | Normal prostate (3) Prostate carcinoma (22) | 22,283 | 2 |
Tomlins | 17173048 | Benign prostate (22) Prostate carcinoma (30) | 19,355 | 2 |
Vanaja | 12873976 | Normal prostate (8) Prostate adenocarcinoma (27) | 44,928 | 2 |
Varambally | 16286247 | Benign prostate (6) Prostate carcinoma (7) | 54,675 | 2 |
Welsh | 11507037 | Normal prostate (9) Prostate carcinoma (25) | 11,138 | 2 |
Yu | 15254046 | Normal prostate (23) Prostate carcinoma (64) | 12,625 | 2 |
Dhanasekaran | 11518967 | Primary prostate cancer (59) Metastatic prostate cancer (20) | 9,935 | 3 |
Dhanasekaran_2 | 15548588 | Prostate cancer (25) Metastatic prostate cancer (6) | 18,502 | 3 |
Tomlins | 17173048 | Prostate carcinoma (30) Metastatic prostate cancer (19) | 19,337 | 3 |
Yu | 15254046 | Prostate carcinoma (64) Metastatic prostate cancer (25) | 12,625 | 3 |
Vanaja | 12873976 | Prostate adenocarcinoma (27) Metastatic prostate cancer (5) | 44,928 | 3 |
Holzbeierlein | 14695335 | Prostate cancer (23) Metastatic prostate cancer (9) | 6,475 | 3 |
LaTulippe | 12154061 | Prostate carcinoma (23) Metastatic prostate cancer (9) | 12,600 | 3 |